2003
DOI: 10.1016/s0968-0896(03)00521-2
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of bovine plasma amine oxidase by 1,4-diamino-2-butenes and -2-butynes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
27
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 29 publications
(27 citation statements)
references
References 26 publications
0
27
0
Order By: Relevance
“…Although it is unlikely that these drugs could be refined to preclude binding to all human CuAOs to help alleviate the side‐effects involved in their use as antidepressants acting on flavin‐containing amine oxidases, the exquisite substrate specificity of the CuAOs could allow these types of drugs to act as lead compounds in the rational design of drugs against HuPAO, whose action is linked to the vascular changes in late diabetic complications and congestive heart disease. As the human CuAOs are further studied, links to other diseases are likely to emerge, and the inherent differing specificities of these enzymes may allow a new palette of drugs to be designed from this original class of MAOI antidepressants to complement other mechanism‐based compounds [36,37] or peptides [38].…”
Section: Resultsmentioning
confidence: 99%
“…Although it is unlikely that these drugs could be refined to preclude binding to all human CuAOs to help alleviate the side‐effects involved in their use as antidepressants acting on flavin‐containing amine oxidases, the exquisite substrate specificity of the CuAOs could allow these types of drugs to act as lead compounds in the rational design of drugs against HuPAO, whose action is linked to the vascular changes in late diabetic complications and congestive heart disease. As the human CuAOs are further studied, links to other diseases are likely to emerge, and the inherent differing specificities of these enzymes may allow a new palette of drugs to be designed from this original class of MAOI antidepressants to complement other mechanism‐based compounds [36,37] or peptides [38].…”
Section: Resultsmentioning
confidence: 99%
“…In these features, the reaction does not differ from those of typical plant CAO substrates like putrescine or cadaverine. GPAO and OVAO inactivation caused by the substrate DAPY fulfills the criteria of a mechanismbased inhibition: it is time dependent, irreversible and can be weakened in the presence of a normal substrate [5,7,11,22].…”
Section: Discussionmentioning
confidence: 99%
“…There are detailed reports on the mechanism-based inhibition of CAOs by DABY in the literature [7][8][9][10][11]. The authors have shown that DABY is oxidized to 4-amino-2-butynal, which induces inactivation by adducting to a nucleophile in the substrate channel.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations